Updated federal regulations will make opioid drug treatments more accessible
For the first time in more than 20 years, the Department of Health and Human Services has updated its regulations on opioid drug treatment.
Share:
More Stories
1:42
Fitness in Four: Loosen up anywhere with these stretches
19h ago3:20
be Well: Preventative care during Women’s Health Awareness Month
19h ago1:45
Missed swim lessons due to COVID-19 may be contributing to rise in child drownings
yesterday1:43
Fairfield County Heart Walk raises money for research and medical breakthroughs
2ds ago1:43
CDC urges people to get vaccinated amid resurgence of mpox
2ds ago1:51
‘Coming together for purpose.’ Mombies Mother's Day 5K raises money for breast cancer research
3ds ago1:42
Fitness in Four: Loosen up anywhere with these stretches
19h ago3:20
be Well: Preventative care during Women’s Health Awareness Month
19h ago1:45
Missed swim lessons due to COVID-19 may be contributing to rise in child drownings
yesterday1:43
Fairfield County Heart Walk raises money for research and medical breakthroughs
2ds ago1:43
CDC urges people to get vaccinated amid resurgence of mpox
2ds ago1:51
‘Coming together for purpose.’ Mombies Mother's Day 5K raises money for breast cancer research
3ds agoFor the first time in more than 20 years, the Department of Health and Human Services has updated its regulations on opioid drug treatment, which will give people with opioid use disorder more access to medications and telehealth to help them wean off drugs.
"The addiction treatment industry for a long time was very big on…everyone must detox, everyone must go inpatient. And while there's definitely a place for that, we know that the science actually shows medications for opioid use disorder – methadone, suboxone, vivitrol – can actually work. They don't have to go through those violent withdrawal processes," says Sarah Howroyd, MSW, LICSW, of CT Hope Initiative.
More than $33 million from a $350 million lawsuit settlement, paid by an ad agency that worked on Purdue Pharma's OxyContin, is coming to the tri-state area within the next two months. A total of 85% is designed for opioid addiction prevention, intervention, treatment and recovery.
